Clinical Trial Update: Telithromycin in Respiratory Tract Infections [Phase 4]

View source ↗

Summary

This update reports completion of a Phase 4 trial evaluating telithromycin for respiratory tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• Telithromycin (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Respiratory Tract Infections | Phase 4 | Status: COMPLETED